Intravenous Immunoglobulin Market: In-Depth Insights into Market Dynamics, Competitive Strategies, and Emerging Trends
The intravenous immunoglobulin market size is projected to grow from USD 12.27 Billion in 2024 to USD 22.88 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.90% during the forecast period (2024 - 2032). The Intravenous Immunoglobulin (IVIG) market is witnessing significant growth as a crucial component in the treatment of various autoimmune and immunodeficiency disorders. Intravenous Immunoglobulin therapy, commonly known as IVIG treatment, involves the administration of immunoglobulin intravenously to enhance the body's immune response. IVIG is derived from pooled human plasma and contains antibodies that can help modulate the immune system. It is utilized in the management of conditions such as primary immunodeficiency disorders, autoimmune diseases, and neurological disorders. The global Intravenous Immunoglobulin market is driven by the increasing prevalence of immune system-related disorders and the growing awareness about the therapeutic ...